Both in Pharmaceuticals

Zentalis Pharmaceuticals vs Lifecore Biomedical

Over the past year ZNTL returned +82.2% and LFCR returned −7.8%; their daily moves had a correlation of 0.07.

ZNTL +82.2% LFCR −7.8%Growth of $1, one year, split-adjusted
MetricZNTLLFCR
Price$2.72$6.59
Market cap$257.0M$249.8M
Today+4.42%+1.07%
1 month−28.6%+45.2%
6 months+26.9%+73.9%
Year to date+101.1%−19.4%
1 year+75.2%−6.0%
Revenue growth (YoY)——
Gross margin—35.3%
Net margin—−20.9%
P/E (TTM)——
Price / sales——
Net cash$174.6M-$136.9M
Dividend yield——
Volatility (60d)76.5%103.3%
Short % of float9.6%9.6%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

ZNTL vs LFCR: Zentalis Pharmaceuticals vs Lifecore Biomedical Stock Comparison | Gainbot